Granza Bio Raises $7M+ Seed Funding to Advance the Delivery of Cancer Treatment and Genetic Medicines

SAN FRANCISCO, July 10, 2024 /PRNewswire/ — Therapeutic delivery platform Granza Bio announced today the close of its oversubscribed $7.14M Seed led by Felicis and Refactor, along with Y Combinator and notable angel investors. “We discovered a new feature of the immune system that has…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks